(Q34581475)

3 August 2017

1 reference

title

Therapeutic potential of serotonin antagonists in depressive disorders (English)

1 reference

3 August 2017

Martyn D Wood

1

1 reference

3 August 2017

David R Thomas

series ordinal

2

1 reference

3 August 2017

Jeannette M Watson

series ordinal

3

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

Expert Opinion on Investigational Drugs

3 August 2017

1 reference

3 August 2017

11

1 reference

3 August 2017

4

1 reference

3 August 2017

457-467

1 reference

The biochemistry of affective disorders

3 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

Abnormalities of indoleamines in affective disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

Current advances and trends in the treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

Serotonin function and depression: neuroendocrine and mood responses to intravenous L-tryptophan in depressed patients and healthy comparison subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

Neuroendocrine and behavioral responses to intravenous m-chlorophenylpiperazine (mCPP) in depressed patients and healthy comparison subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

The molecular biology of serotonin receptors: therapeutic implications for the interface of mood and psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

5-HT1A receptors in the median raphe nucleus and dorsal hippocampus may mediate anxiolytic and anxiogenic behaviours respectively.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

Effects of centrally administered anxiolytic compounds in animal models of anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

Dissecting the role of the serotonin system in neuropsychiatric disorders using knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

The selective serotonin (5-HT)1A receptor ligand, S15535, displays anxiolytic-like effects in the social interaction and Vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely-moving rats. A comparison with other an

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

Effects of 8-OHDPAT and 5-HT1A antagonists WAY100135 and WAY100635, on guinea-pig behaviour and dorsal raphe 5-HT neurone firing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

Effect of pindolol on the function of pre- and postsynaptic 5-HT1A receptors: in vivo microdialysis and electrophysiological studies in the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

Raphe 5-HT1A autoreceptors, but not postsynaptic 5-HT1A receptors or beta-adrenoceptors, restrain the citalopram-induced increase in extracellular 5-hydroxytryptamine in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

Latency to paroxetine-induced anxiolysis in the rat is reduced by co-administration of the 5-HT(1A) receptor antagonist WAY100635.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

beta-blocker binding to human 5-HT(1A) receptors in vivo and in vitro: implications for antidepressant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

GR127935: a potent and selective 5-HT1D receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

Co-localization of 5-HT1B- and 5-HT1D receptor mRNA in serotonergic cell bodies in guinea pig dorsal raphé nucleus: a double labeling in situ hybridization histochemistry study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

Evidence that 5-hydroxytryptamine release in rat dorsal raphé nucleus is controlled by 5-HT1A, 5-HT1B and 5-HT1D autoreceptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

5-HT1D as well as 5-HT1A autoreceptors modulate 5-HT release in the guinea-pig dorsal raphé nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

SB-236057, a selective 5-HT1B receptor inverse agonist, blocks the 5-HT human terminal autoreceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

The effect of SB-236057-A, a selective 5-HT1B receptor inverse agonist, on in vivo extracellular 5-HT levels in the freely-moving guinea-pig

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

Interaction of serotonin autoreceptor antagonists in the rat dorsal raphe nucleus: an in vitro fast cyclic voltammetry study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

5-HT1B Autoreceptors limit the effects of selective serotonin re-uptake inhibitors in mouse hippocampus and frontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

Enhancement of 5-HT1B and 5-HT1D receptor antagonist effects on extracellular 5-HT levels in the guinea-pig brain following concurrent 5-HT1A or 5-HT re-uptake site blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

5-HT2 receptor characteristics in frontal cortex and 5-HT2 receptor-mediated head-twitch behaviour following antidepressant treatment to mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

The neurobiology of suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

Serotonergic responsivity in obsessive-compulsive disorder. Comparison of patients and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

mCPP-induced anxiety in the light-dark box in rats--a new method for screening anxiolytic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

Brain 5-HT2A receptor occupancy of deramciclane in humans after a single oral administration--a positron emission tomography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

Human 5-HT(5) receptors: the 5-HT(5A) receptor is functional but the 5-HT(5B) receptor was lost during mammalian evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

Cloning and characterisation of the human 5-HT5A serotonin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

Localization of serotonin(5A) receptors in discrete regions of the circadian timing system in the Syrian hamster

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

Depression and sleep disorders: clinical relevance, economic burden and pharmacological treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

Characterization of Ro 04-6790 and Ro 63-0563: potent and selective antagonists at human and rat 5-HT6 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

Characterization of SB-271046: a potent, selective and orally active 5-HT(6) receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

5-HT7 receptors: current knowledge and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

Localization of 5-HT(7) receptors in rat brain by immunocytochemistry, in situ hybridization, and agonist stimulated cFos expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

5-CT stimulation of adenylyl cyclase activity in guinea-pig hippocampus: evidence for involvement of 5-HT7 and 5-HT1A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

5HT7 receptors in the rodent suprachiasmatic nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

Effects of antidepressants on 5-HT7 receptor regulation in the rat hypothalamus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

Tetrahydrobenzindoles: selective antagonists of the 5-HT7 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

Atropisomeric derivatives of 2',6'-disubstituted (R)-11-phenylaporphine: selective serotonin 5-HT(7) receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

(R)-3,N-dimethyl-N-[1-methyl-3-(4-methyl-piperidin-1-yl) propyl]benzenesulfonamide: the first selective 5-HT7 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

A novel, potent, and selective 5-HT(7) antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl) phen ol (SB-269970).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

Characterization of SB-269970-A, a selective 5-HT(7) receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

5-HT1A receptor activation and antidepressant-like effects: F 13714 has high efficacy and marked antidepressant potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.457

10.1517/13543784.11.4.457

21 January 2018

Identifiers

DOI

1 reference

release_hvnbfluecvel3bcohuzrlga4j4

3 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hvnbfluecvel3bcohuzrlga4j4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference